Minnesota HF2703 extends the prohibition on manufacturers interfering with access to 340B drugs.

Minnesota HF2703 repeals the expiration date for the prohibition on manufacturers interfering with access to 340B drugs, ensuring the restriction remains in place. This bill affects drug manufacturers and entities covered under the 340B Drug Discount Program, which provides discounted drugs to certain federal grantees. The prohibition now has no expiration date, maintaining the current legal framework indefinitely.

Minnesota HF2703 extends the prohibition on manufacturers interfering with access to 340B drugs.

Minnesota HF2703 repeals the expiration date for the prohibition on manufacturers interfering with access to 340B drugs, ensuring the restriction remains in place. This bill affects drug manufacturers and entities covered under the 340B Drug Discount Program, which provides discounted drugs to certain federal grantees. The prohibition now has no expiration date, maintaining the current legal framework indefinitely.